New bacterial mRNA vaccine technology shows promise in fighting plague, and could help address the global threat of ...

TAU’s vice president for research and development said that they worked on the project for two-and-a-half years and were very satisfied with their discoveries.

Scientists in Tel Aviv and IIBR have developed an mRNA vaccine. It combats the deadly Yersinia pestis bacterium. This bacterium causes plague. The vaccine showed 100% effectiveness in animal trials.

A Coconino County resident died of a rare case of pneumonic plague earlier this month. Dave Wagner, director of Northern ...

Scientists from Tel Aviv University and the Israel Institute of Biological Research say their vaccine uses lipid ...

"New Vaccine Protects Monkeys From Pneumonic Plague." ScienceDaily. www.sciencedaily.com / releases / 2008 / 12 / 081219093756.htm (accessed June 4, 2025). Explore More ...

Unfortunately, over 100 years of research have yet to generate a safe and effective pneumonic plague vaccine. Haffkine described the first widely used vaccine in 1897.

There is no licensed plague vaccine in the United States. ... Plague infections of the lung, known as pneumonic plague, ... This research is focused primarily on thwarting the use of plague as a ...

Researchers from Tel Aviv University and the Israel Institute for Biological Research in Ness Ziona have used the platform ...

Pneumonic plague, caused by the bacterium Yersinia pestis, remains a subject of intense scientific scrutiny given its historical impact and potential modern threat. Research has elucidated the ...

The history and status of plague vaccine research is discussed. Learn why pneumonic plague vaccines should strive to prime both humoral and cellular immunity.